...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
【24h】

In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates

机译:Bedaquiline和Delamanid的体外活性对抗非泛族分枝杆菌,包括耐大氯化物抗性临床分离株

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the in vitro activities of the antimicrobial drugs bedaquiline and delamanid against the major pathogenic nontuberculous mycobacteria (NTM). Delamanid showed high MIC values for all NTM except Mycobacterium kansasii. However, bedaquiline showed low MIC values for the major pathogenic NTM, including Mycobacterium avium complex, Mycobacterium abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. kansasii. Bedaquiline also had low MIC values with macrolide-resistant NTM strains and warrants further investigation as a potential antibiotic for NTM treatment.
机译:我们评估了抗菌药物Bedaquiline和Delamanid对主要致病性的分枝杆菌(NTM)的体外活性。 Delamanid显示除Cycobacterium Kansasii外的所有NTM的高麦克风值。 然而,Bedaquiline显示出主要致病性NTM的低MIC值,包括分枝杆菌亚溴术,分枝杆菌脓肿患者。 脓肿,M. Abscessus Subsp。 Massiliense和M. Kansasii。 Bedaquiline还具有低MIC值,具有大氯化物抗性NTM菌株,并根据NTM治疗的潜在抗生素进行进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号